Clinical Trial Update: Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies [Phase 4]

View source ↗

Summary

Phase 4 trial investigating switched memory B-cells as a marker for humoral immune system recovery in patients with secondary antibody deficiency due to hematol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody Deficiency
• Hematological Malignancies

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Secondary Antibody Deficiency | Phase 4 | Status: UNKNOWN